Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-asthma drugs].

P Devillier1

  • 1Laboratoire de pharmacologie-toxicologie, Hôpital Maison Blanche, Centre hospitalier universitaire de Reims 51092 Reims. pdevillier@chu-reims.fr

La Revue Du Praticien
|May 11, 2001
PubMed
Summary

Anti-asthma drugs include bronchodilators like beta 2-agonists for symptom relief and anti-inflammatory drugs such as inhaled corticosteroids for persistent asthma control. These medications help manage asthma symptoms and prevent exercise-induced asthma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laser peripheral iridotomy for dark-induced angle closure changes: A proof-of-concept study.

Journal francais d'ophtalmologie·2026
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same author

[Real-life utilization of fixed triple therapy in COPD: The Trilife study. Beclomethasone/formoterol/glycopyrronium triple fixed-dose therapy in extra-fine particles].

Revue des maladies respiratoires·2024
Same author

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Allergy·2023
Same author

Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.

Pulmonology·2022
Same author

[Take-home messages from the COPD 2021 biennial of the French Society of Respiratory Diseases. Understanding to so as to better innovate].

Revue des maladies respiratoires·2022

Area of Science:

  • Pharmacology
  • Respiratory Medicine

Context:

  • Asthma management involves addressing both bronchoconstriction and airway inflammation.
  • Current treatments include bronchodilators and anti-inflammatory agents.

Purpose:

  • To classify and describe the mechanisms of action for various anti-asthma drugs.
  • To outline their therapeutic applications in different asthma severities and specific conditions like exercise-induced asthma.

Summary:

  • Anti-asthma drugs are categorized as bronchodilators (e.g., inhaled beta 2-agonists) or anti-inflammatory agents (e.g., inhaled corticosteroids).
  • Short-acting beta 2-agonists provide acute symptom relief, while long-acting beta 2-agonists are used for long-term control with inhaled corticosteroids.
  • Other options include methylxanthines, anticholinergics, anti-leukotrienes (e.g., montelukast), cromones, and ketotifen, with specific roles in persistent or exercise-induced asthma.

Impact:

  • Provides a clear overview of the pharmacological landscape for asthma treatment.
  • Helps clinicians and patients understand the appropriate use of different drug classes for effective asthma control.

Related Experiment Videos